financetom
Business
financetom
/
Business
/
Moody's forecasts annual profit above estimates on robust demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Moody's forecasts annual profit above estimates on robust demand
Feb 13, 2025 5:40 AM

(Reuters) - Ratings agency Moody's Corp forecast 2025 profit above Wall Street estimates on Thursday, anticipating strong demand for its data and analytics offerings amid macroeconomic ambiguity, sending its shares up over 3% in premarket trading.

Demand for market analytical tools has risen as investors try to capture value amid diminishing chances of interest rate cuts and rising uncertainty over the economic impact of the U.S. administration's trade, immigration and fiscal policies.

S&P Global ( SPGI ), Moody's peer, also forecast 2025 adjusted profit above analysts' estimates on Tuesday.

Moody's forecast an annual adjusted profit of $14 per share to $14.50 per share, above analysts' estimates of $13.58, according to data compiled by LSEG.

Its adjusted profit of $2.62 per share in the fourth quarter also exceeded analysts' expectation of $2.59.

Total revenue increased 13% to $1.67 billion, powered by an 8.4% rise in its analytics unit and a 17.2% jump in its investor service business. Both units have a roughly equal contribution.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Applied DNA Sciences (APDN) Stock Is Rising
Why Applied DNA Sciences (APDN) Stock Is Rising
Apr 1, 2025
Applied DNA Sciences Inc ( APDN ) shares are trading higher by 6.0% to $1.76 during Tuesday’s session after the company announced it positioned its TR8 PGx testing as pre-emptive testing for therapeutic safety. What To Know: Applied DNA Sciences ( APDN ) on Tuesday announced that its subsidiary, Applied DNA Clinical Labs (ADCL), is refining its TR8 PGx pharmacogenomics...
Update: Eli Lilly Reportedly Sues More Drug Compounders for Copying Weight Loss Drug
Update: Eli Lilly Reportedly Sues More Drug Compounders for Copying Weight Loss Drug
Apr 1, 2025
12:00 PM EDT, 04/01/2025 (MT Newswires) -- (Updates with statement from Eli Lilly ( LLY ) spokesperson in the last two paragraphs.) Eli Lilly ( LLY ) is going after two more drug compounders that continue to make and sell copies of its weight loss drug despite a March court order against it, multiple media outlets reported Tuesday. The company's...
Toyota Motor US Sales Rise in March, Q1
Toyota Motor US Sales Rise in March, Q1
Apr 1, 2025
12:03 PM EDT, 04/01/2025 (MT Newswires) -- Toyota Motor's ( TM ) North American unit said Tuesday that US sales in March were up 7.7% on a volume basis to 231,335 compared to a year ago. For Q1, the sales totaled 570,269 vehicles, up 0.9% on a volume basis from the year-ago period. Sales of electrified vehicles for March and...
Update: MDA Space Down 5% as Says to Acquire NYSE American-listed SatixFy Communications for US$193 Million
Update: MDA Space Down 5% as Says to Acquire NYSE American-listed SatixFy Communications for US$193 Million
Apr 1, 2025
12:03 PM EDT, 04/01/2025 (MT Newswires) -- (Updates shares.) MDA Space ( MDALF ) said Tuesday that it agreed to acquire SatixFy Communications ( SATX ) for US$193 million. MDA will pay US$2.10 per share for SatixFy, which supplies semiconductors and solutions for the space and the satellite communications value chain. Its technology enables satellite broadband and direct-to-device constellations with...
Copyright 2023-2026 - www.financetom.com All Rights Reserved